Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 56, Issue 1, 2003, Pages 114-120

  Gopal, Ramesh ^a   Starkschall, George ^a   Tucker, Susan L ^a   Cox, James D ^a   Liao, Zhongxing ^a   Hanus, Michael ^a   Kelly, Jason F ^a   Stevens, Craig W ^a   Komaki, Ritsuko ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Diffusion capacity; Lung cancer; Pulmonary toxicity; Radiotherapy

Indexed keywords

CHEMOTHERAPY; PATIENT TREATMENT; RADIOTHERAPY; TUMORS;

THORACIC RADIOTHERAPY (RT);

PULMONARY DISEASES;

CARBON MONOXIDE; CISPLATIN; ETOPOSIDE; VINBLASTINE;

ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL ASSESSMENT; PREDICTION; PRIORITY JOURNAL; TOTAL LUNG CAPACITY; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR VOLUME; VITAL CAPACITY;

EID: 0344838593     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00077-4     Document Type: Article

References (36)

1. Marks L.B. The pulmonary effects of thoracic irradiation. Oncology (Huntingt). 8:1994;89-106.
2. Theuws J.C., Muller S.H., Seppenwoolde Y., et al. Effect of radiotherapy and chemotherapy on pulmonary function after treatment for breast cancer and lymphoma A follow-up study . J Clin Oncol. 17:1999;3091-3100.
3. Marks L.B., Munley M.T., Bentel G.C., et al. Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys. 39:1997;563-570.
4. Rubenstein J.H., Richter M.P., Moldofsky P.J., et al. Prospective prediction of post-radiation therapy lung function using quantitative lung scans and pulmonary function testing. Int J Radiat Oncol Biol Phys. 15:1988;83-87.
5. Choi N.C., Kanarek D.J., Kazemi H. Physiologic changes in pulmonary function after thoracic radiotherapy for patients with lung cancer and role of regional pulmonary function studies in predicting postradiotherapy pulmonary function before radiotherapy. Cancer Treat Symp. 1985:1985;119-130.
6. Theuws J.C., Kwa S.L., Wagenaar A.C., et al. Prediction of overall pulmonary function loss in relation to the 3-D dose distribution for patients with breast cancer and malignant lymphoma. Radiother Oncol. 49:1998;233-243.
7. Boersma L.J., Damen E.M., de Boer R.W., et al. Estimation of overall pulmonary function after irradiation using dose-effect relations for local functional injury. Radiother Oncol. 36:1995;15-23.
8. Fan M., Marks L.B., Hollis D., et al. Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction? J Clin Oncol. 19:2001;543-550.
9. Fan M., Marks L.B., Lind P., et al. Relating radiation-induced regional lung injury to changes in pulmonary function tests. Int J Radiat Oncol Biol Phys. 51:2001;311-317.
10. Robert F., Childs H.A., Spencer S.A., et al. Phase I/IIa study of concurrent paclitaxel, and cisplatin with radiation therapy in locally advanced non-small cell lung cancer Analysis of early and late pulmonary morbidity . Semin Radiat Oncol. 9:1999;136-147.
11. Brooks B.J. Jr, Seifter E.J., Walsh T.E., et al. Pulmonary toxicity with combined modality therapy for limited stage small-cell lung cancer. J Clin Oncol. 4:1986;200-209.
12. Lund M.B., Kongerud J., Nome O., et al. Lung function impairment in long-term survivors of Hodgkin's disease. Ann Oncol. 6:1995;495-501.
13. Brizel D.M., Wasserman T.H., Henke M., et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol. 18:2000;3339-3345.
14. Tannehill S.P., Mehta M.P., Larson M., et al. Effect of amifostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small-cell lung cancer Results of a phase II trial . J Clin Oncol. 15:1997;2850-2857.
15. Antonadou D., Coliarakis N., Synodinou M., et al. Randomized phase III trial of radiation treatment ± amifostine in patients with advanced-stage lung cancer. Int J Radiat Oncol Biol Phys. 51:2001;915-922.
16. Lung function testing Selection of reference values and interpretative strategies . Am Rev Respir Dis. 144:1991;1202-1218.
17. Baltagi B.H. Econometric analysis of panel data. 1985;John Wiley & Sons, New York.
18. Marks L.B., Hollis D., Munley M., et al. The role of lung perfusion imaging in predicting the direction of radiation-induced changes in pulmonary function tests. Cancer. 88:2000;2135-2141.
19. McDonald S., Rubin P., Phillips T.L., et al. Injury to the lung from cancer therapy Clinical syndromes, measurable endpoints, and potential scoring systems . Int J Radiat Oncol Biol Phys. 31:1995;1187-1203.
20. Marks L.B. The impact of organ structure on radiation response. Int J Radiat Oncol Biol Phys. 34:1996;1165-1171.
21. Ferguson M.K., Reeder L.B., Mick R. Optimizing selection of patients for major lung resection. J Thorac Cardiovasc Surg. 109:1995;275-281.
22. Prato F.S., Kurdyak R., Saibil E.A., et al. Regional and total lung function in patients following pulmonary irradiation. Invest Radiol. 12:1977;224-237.
23. Marks L.B., Munley M.T., Spencer D.P., et al. Quantification of radiation-induced regional lung injury with perfusion imaging. Int J Radiat Oncol Biol Phys. 38:1997;399-409.
24. Levinson B., Marks L.B., Munley M.T., et al. Regional dose response to pulmonary irradiation using a manual method. Radiother Oncol. 48:1998;53-60.
25. Marks L.B., Sherouse G.W., Munley M.T., et al. Incorporation of functional status into dose-volume analysis. Med Phys. 26:1999;196-199.
26. Theuws J.C., Kwa S.L., Wagenaar A.C., et al. Dose-effect relations for early local pulmonary injury after irradiation for malignant lymphoma, and breast cancer. Radiother Oncol. 48:1998;33-43.
27. Theuws J.C., Seppenwoolde Y., Kwa S.L., et al. Changes in local pulmonary injury up to 48 months after irradiation for lymphoma and breast cancer. Int J Radiat Oncol Biol Phys. 47:2000;1201-1208.
28. Seppenwoolde Y., Muller S.H., Theuws J.C., et al. Radiation dose-effect relations and local recovery in perfusion for patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 47:2000;681-690.
29. Boersma L.J., Damen E.M., de Boer R.W., et al. Recovery of overall and local lung function loss 18 months after irradiation for malignant lymphoma. J Clin Oncol. 14:1996;1431-1441.
30. Allavena C., Conroy T., Aletti P., et al. Late cardiopulmonary toxicity after treatment for Hodgkin's disease. Br J Cancer. 65:1992;908-912.
31. Abratt R.P., Willcox P.A., Salton D.G. Concurrent radiation and weekly cisplatin for non-small-cell lung cancer - A phase I/II study. Cancer Chemother Pharmacol. 30:1992;495-497.
32. Kimsey F.C., Mendenhall N.P., Ewald L.M., et al. Is radiation treatment volume a predictor for acute or late effect on pulmonary function? A prospective study of patients treated with breast-conserving surgery and postoperative irradiation. Cancer. 73:1994;2549-2555.
33. Capizzi R.L. The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine. Semin Oncol. 26:1999;3-21.
34. Down J.D., Laurent G.J., McAnulty R.J., et al. Oxygen-dependent protection of radiation lung damage in mice by WR 2721. Int J Radiat Biol Relat Stud Phys Chem Med. 46:1984;597-607.
35. Gridelli C., Guida C., Barletta E., et al. Thoracic radiotherapy and daily vinorelbine as radiosensitizer in locally advanced non small cell lung cancer A phase I study . Lung Cancer. 29:2000;131-137.
36. Komaki R., Lee J.S., Kaplan B., et al. Randomized phase III study of amifostine in patients treated with chemoradiation for inoperable stage II-III non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 51(Suppl 1):2001;19.